Merck Applies For Approval For It’s New Oral Anti-Viral Drug Treatment

Merck Applies For Approval For It’s New Oral Anti-Viral Drug Treatment

Drugmaker Merck has asked US regulators to authorize its pill for treating COVID-19 in what would add an entirely new and easy-to-use weapon to the world’s arsenal against the pandemic. Merck reported earlier this month that in clinical trials, the pill cut hospitalizations and deaths by half among patients with early symptoms of COVID-19. Since the pandemic started, health experts have stressed the need for a convenient pill that would be something like Tamiflu, the flu medication that shortens the illness and blunts the severity of symptoms.

Photo Credit: Merck via Twitter

After 9 Podcast - 91.5 The Beat